Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

Preliminary Efficacy, Safety and Pharmacokinetics Study of Nepadutant in Infant With Feeding Intolerance

ClinicalTrials.gov ID: NCT01532518

Public ClinicalTrials.gov record NCT01532518. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 22, 2026, 3:32 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multicenter, Open Label, Ascending 7 Day-Repeated Dose Study to Investigate Efficacy, Safety and Pharmacokinetics of Nepadutant In Infants With Feeding Intolerance

Study identification

NCT ID
NCT01532518
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Menarini Group
Industry
Enrollment
27 participants

Conditions and interventions

Conditions

Interventions

  • Nepadutant Drug

Drug

Eligibility (public fields only)

Age range
Up to 6 Months
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jul 31, 2011
Primary completion
Jun 30, 2012
Completion
Jun 30, 2012
Last update posted
May 5, 2023

2011 – 2012

United States locations

U.S. sites
5
U.S. states
5
U.S. cities
5
Facility City State ZIP Site status
Arkansas Children's Hospital Little Rock Arkansas 72202
Children's Center for Digestive Healthcare Atlanta Georgia 30342
Kosair Charities Pediatric Clinical Research Unit / University of Louisville Louisville Kentucky 40202
SUNY Downstate Medical Center Albany New York 12207
The University of Toledo College of Medicine\The Toledo Children's Hospital Toledo Ohio 43606

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01532518, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 5, 2023 · Synced Jul 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01532518 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →